Competitor Viagra

Last Friday, the Control over products and medicines of the United States of America (FDA) approved a new fast medicine called Stendra, which is intended for the treatment of erectile dysfunction. This information tells USA Today. Vivus Inc is the official manufacturer of the new drug, which will soon become obvious competitor of viagra.

The active ingredient, which is part Stendra - avanafil. The drug inhibits phosphodiesterase 5 of the first kind and is the drug of the same group as the notorious "Viagra", "Cialis and Levitra. The effect of the drug when sexual excitation is the dilation of blood vessels of the penis, the blood flow in it is gradually increased, followed by a prolonged erection.

All patients who need this drug, it is recommended to take it thirty minutes before the start of sexual intercourse. However, clinical trials showed that the drug begins to act within fifteen minutes. The time until the expected effect of other similar medicines ranges from twenty minutes to a full hour.

Clinical trials of the drug showed that two percent of patients had side effects such as headache, nasal congestion and redness of the skin. Sometimes arose hearing and vision.

The FDA say that the appearance of more than one medication to treat erectile dysfunction, will undoubtedly increase the number of available drugs for the treatment and gives an excellent opportunity for patients to choose the most suitable one.

Subscribe to new posts: